Literature DB >> 25564660

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

Daniel F Vatner1, Sachin K Majumdar1, Naoki Kumashiro1, Max C Petersen2, Yasmeen Rahimi1, Arijeet K Gattu3, Mitchell Bears1, João-Paulo G Camporez1, Gary W Cline1, Michael J Jurczak1, Varman T Samuel4, Gerald I Shulman5.   

Abstract

A central paradox in type 2 diabetes is the apparent selective nature of hepatic insulin resistance--wherein insulin fails to suppress hepatic glucose production yet continues to stimulate lipogenesis, resulting in hyperglycemia, hyperlipidemia, and hepatic steatosis. Although efforts to explain this have focused on finding a branch point in insulin signaling where hepatic glucose and lipid metabolism diverge, we hypothesized that hepatic triglyceride synthesis could be driven by substrate, independent of changes in hepatic insulin signaling. We tested this hypothesis in rats by infusing [U-(13)C] palmitate to measure rates of fatty acid esterification into hepatic triglyceride while varying plasma fatty acid and insulin concentrations independently. These experiments were performed in normal rats, high fat-fed insulin-resistant rats, and insulin receptor 2'-O-methoxyethyl chimeric antisense oligonucleotide-treated rats. Rates of fatty acid esterification into hepatic triglyceride were found to be dependent on plasma fatty acid infusion rates, independent of changes in plasma insulin concentrations and independent of hepatocellular insulin signaling. Taken together, these results obviate a paradox of selective insulin resistance, because the major source of hepatic lipid synthesis, esterification of preformed fatty acids, is primarily dependent on substrate delivery and largely independent of hepatic insulin action.

Entities:  

Keywords:  esterification; hepatic insulin resistance; lipogenesis; mass spectrometry; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2015        PMID: 25564660      PMCID: PMC4313795          DOI: 10.1073/pnas.1423952112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes.

Authors:  P K Shah; S Mudaliar; A R Chang; V Aroda; M Andre; P Burke; R R Henry
Journal:  Diabetes Obes Metab       Date:  2011-06       Impact factor: 6.577

2.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Authors:  Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

3.  Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

Authors:  Renaud Dentin; Fadila Benhamed; Isabelle Hainault; Véronique Fauveau; Fabienne Foufelle; Jason R B Dyck; Jean Girard; Catherine Postic
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

4.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice.

Authors:  Susanne Neschen; Katsutaro Morino; Linda E Hammond; Dongyan Zhang; Zhen-Xiang Liu; Anthony J Romanelli; Gary W Cline; Rebecca L Pongratz; Xian-Man Zhang; Cheol S Choi; Rosalind A Coleman; Gerald I Shulman
Journal:  Cell Metab       Date:  2005-07       Impact factor: 27.287

6.  Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans.

Authors:  Aruna Vedala; Wei Wang; Richard A Neese; Mark P Christiansen; Marc K Hellerstein
Journal:  J Lipid Res       Date:  2006-08-23       Impact factor: 5.922

7.  Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes.

Authors:  Leena Juurinen; Mirja Tiikkainen; Anna-Maija Häkkinen; Antti Hakkarainen; Hannele Yki-Järvinen
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-11-07       Impact factor: 4.310

8.  Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.

Authors:  Shijie Li; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 9.  Selective versus total insulin resistance: a pathogenic paradox.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

Review 10.  Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models.

Authors:  Peter J Voshol; Patrick C N Rensen; Ko Willems van Dijk; Johannes A Romijn; Louis M Havekes
Journal:  Biochim Biophys Acta       Date:  2009-01-08
View more
  85 in total

1.  Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.

Authors:  Diana K Costa; Brydie R Huckestein; Lia R Edmunds; Max C Petersen; Ali Nasiri; Gina M Butrico; Abudukadier Abulizi; Daniel B Harmon; Canying Lu; Benjamin S Mantell; Douglas J Hartman; João-Paulo G Camporez; Robert M O'Doherty; Gary W Cline; Gerald I Shulman; Michael J Jurczak
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-10       Impact factor: 4.310

2.  Diabetes: Hepatic lipogenesis independent of insulin in type 2 diabetes mellitus--a paradox clarified.

Authors:  Joana Osório
Journal:  Nat Rev Endocrinol       Date:  2015-01-20       Impact factor: 43.330

3.  Differential effects of intrauterine growth restriction and a hypersinsulinemic-isoglycemic clamp on metabolic pathways and insulin action in the fetal liver.

Authors:  Amanda K Jones; Laura D Brown; Paul J Rozance; Natalie J Serkova; William W Hay; Jacob E Friedman; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-13       Impact factor: 3.619

Review 4.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity.

Authors:  Yong Rao; Yu-Ting Lu; Chan Li; Qin-Qin Song; Yao-Hao Xu; Zhao Xu; Yu-Tao Hu; Hong Yu; Lin Gao; Lian-Quan Gu; Ji-Ming Ye; Zhi-Shu Huang
Journal:  Br J Pharmacol       Date:  2019-07-04       Impact factor: 8.739

6.  Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.

Authors:  João Paulo Camporez; Kun Lyu; Emily L Goldberg; Dongyan Zhang; Gary W Cline; Michael J Jurczak; Vishwa Deep Dixit; Kitt Falk Petersen; Gerald I Shulman
Journal:  J Physiol       Date:  2019-07-04       Impact factor: 5.182

Review 7.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

8.  Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.

Authors:  Rakel F Johansen; Esben Søndergaard; Lars Peter Sørensen; Anne Grethe Jurik; Jens S Christiansen; Søren Nielsen
Journal:  Diabetologia       Date:  2016-01-19       Impact factor: 10.122

9.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

Review 10.  Curcumin and dietary polyphenol research: beyond drug discovery.

Authors:  Tian-Ru Jin
Journal:  Acta Pharmacol Sin       Date:  2018-03-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.